Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mast Cells Positive for c-Kit Receptor and Tryptase Correlate with Angiogenesis in Cancerous and Adjacent Normal Pancreatic Tissue.
Ammendola M, Currò G, Laface C, Zuccalà V, Memeo R, Luposella F, Laforgia M, Zizzo N, Zito A, Loisi D, Patruno R, Milella L, Ugenti I, Porcelli M, Navarra G, Gadaleta CD, Ranieri G. Ammendola M, et al. Among authors: laforgia m. Cells. 2021 Feb 19;10(2):444. doi: 10.3390/cells10020444. Cells. 2021. PMID: 33669751 Free PMC article.
An evaluation of masitinib for treating systemic mastocytosis.
Laforgia M, Marech I, Nardulli P, Calabrò C, Gadaleta CD, Ranieri G. Laforgia M, et al. Expert Opin Pharmacother. 2019 Sep;20(13):1539-1550. doi: 10.1080/14656566.2019.1645121. Epub 2019 Aug 5. Expert Opin Pharmacother. 2019. PMID: 31381378 Review.
Pharmacotherapy in Mast Cell Leukemia.
Laforgia M, Calabrò C, Scattone A, Laface C, Porcelli M, Gadaleta CD, Nardulli P, Ranieri G. Laforgia M, et al. Expert Opin Pharmacother. 2020 Jun;21(9):1059-1069. doi: 10.1080/14656566.2020.1744566. Epub 2020 Mar 25. Expert Opin Pharmacother. 2020. PMID: 32208985 Review.
Local treatment with deep percutaneous electrochemotherapy of different tumor lesions: pain relief and objective response results from an observational study.
Ranieri G, Laface C, Fazio V, De Ceglia D, Macina F, Gisone V, Porcelli M, Vinciarelli G, Carella C, Molinari P, Laricchia G, Laforgia M, Gadaleta Cosmo D. Ranieri G, et al. Among authors: laforgia m. Eur Rev Med Pharmacol Sci. 2020 Jul;24(14):7764-7775. doi: 10.26355/eurrev_202007_22279. Eur Rev Med Pharmacol Sci. 2020. PMID: 32744703 Free article.
Bevacizumab Plus FOLFOX-4 Combined With Deep Electro-Hyperthermia as First-line Therapy in Metastatic Colon Cancer: A Pilot Study.
Ranieri G, Laface C, Laforgia M, De Summa S, Porcelli M, Macina F, Ammendola M, Molinari P, Lauletta G, Di Palo A, Rubini G, Ferrari C, Gadaleta CD. Ranieri G, et al. Among authors: laforgia m. Front Oncol. 2020 Nov 3;10:590707. doi: 10.3389/fonc.2020.590707. eCollection 2020. Front Oncol. 2020. PMID: 33224885 Free PMC article.
Corrigendum: Bevacizumab Plus FOLFOX-4 Combined With Deep Electro-Hyperthermia as First-line Therapy in Metastatic Colon Cancer: A Pilot Study.
Ranieri G, Laface C, Laforgia M, De Summa S, Porcelli M, Macina F, Ammendola M, Molinari P, Lauletta G, Di Palo A, Rubini G, Ferrari C, Gadaleta CD. Ranieri G, et al. Among authors: laforgia m. Front Oncol. 2021 Feb 5;10:637880. doi: 10.3389/fonc.2020.637880. eCollection 2020. Front Oncol. 2021. PMID: 33614511 Free PMC article.
32 results